Free Trial
→ I warned you about Nvidia… now look what’s happening (From Timothy Sykes) (Ad) Free SONN Stock Alerts

Sonnet BioTherapeutics (SONN) SEC Filings & 10K Form

Sonnet BioTherapeutics logo
$4.22 -0.35 (-7.66%)
Closing price 04:00 PM Eastern
Extended Trading
$4.32 +0.10 (+2.25%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Sonnet BioTherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/18/2025
3:30 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2025
6:35 PM		Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		MCANDREW STEPHEN J (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
6:35 PM		Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
5:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
5:32 AM		Sonnet BioTherapeutics (Subject)
Form 425
07/02/2025
8:00 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
8:07 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:03 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
8:11 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
8:03 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
8:05 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:48 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:15 PM		Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2025
7:09 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
02/02/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
01/31/2025
3:56 PM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/31/2025
3:57 PM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/30/2025
4:25 PM		Sonnet BioTherapeutics (Filer)
Form S-1/A
01/30/2025
4:25 PM		Sonnet BioTherapeutics (Filer)
Form S-1/A
01/28/2025
8:10 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
01/21/2025
8:17 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 424B3
01/13/2025
3:34 PM		Sonnet BioTherapeutics (Filer)
Form POS AM
12/23/2024
3:05 PM		Sonnet BioTherapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/17/2024
8:00 AM		Sonnet BioTherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/17/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:25 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:20 AM		Sonnet BioTherapeutics (Filer)
Form 424B5
12/09/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
8:55 PM		Cross John Harry III (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Kenney Richard T (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Mohan Pankaj (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
A grave, grave error. (Ad)

Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one analyst who predicted the collapse of Fannie Mae and GM says the AI giant is now headed for a brutal crash… and it could hit as soon as this year.

Watch his urgent Nvidia exposé before it’s too late
12/05/2024
8:55 PM		Griffith Donald J. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Cini John K. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Rao Raghu (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Dyrness Albert D. (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		McNeill Lori (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Dexter Susan (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
8:55 PM		Bhatt Nailesh (Reporting)
Sonnet BioTherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
8:20 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:15 PM		Sonnet BioTherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/08/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
8:22 AM		Sonnet BioTherapeutics (Filer)
Form 424B4
11/06/2024
11:15 PM		Sonnet BioTherapeutics (Filer)
Form EFFECT
11/06/2024
8:22 AM		Sonnet BioTherapeutics (Filer)
Form S-1/A
11/06/2024
7:48 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:01 AM		Sonnet BioTherapeutics (Filer)
Form S-1/A
10/28/2024
8:01 AM		Sonnet BioTherapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/17/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
7:56 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
7:36 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:15 PM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:30 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:27 PM		Sonnet BioTherapeutics (Filer)
Form DEF 14A
08/19/2024
4:28 PM		Sonnet BioTherapeutics (Filer)
Form ARS
08/19/2024
7:50 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:41 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:45 AM		Sonnet BioTherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
4:28 PM		Sonnet BioTherapeutics (Filer)
Form PRE 14A
07/24/2024
7:36 AM		Sonnet BioTherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SONN) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners
Elon Just Fired the IRS Agents Targeting Your Savings
Elon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...
Priority Gold | Sponsored
Why Elon put $51 million into this
A single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...
True Market Insiders | Sponsored
Trump’s Endgame? (R.I.P. China)
Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...
Brownstone Research | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
BREAKING: The House just passed 3 pro-crypto bills!
Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...
Crypto 101 Media | Sponsored
Bitcoin Beats Gold — But This Coin Could Beat Them Both
Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...
Weiss Ratings | Sponsored
Treasury Secretary Bessent Is Betting Big on Gold
When the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...
Golden Portfolio | Sponsored